Cite
Jenkins R, Farnbach K, Iragorri S. Elimination of Intravenous Di-2-Ethylhexyl Phthalate Exposure Abrogates Most Neonatal Hypertension in Premature Infants with Bronchopulmonary Dysplasia. Toxics. 2021;9(4)doi: 10.3390/toxics9040075.
Jenkins, R., Farnbach, K., & Iragorri, S. (2021). Elimination of Intravenous Di-2-Ethylhexyl Phthalate Exposure Abrogates Most Neonatal Hypertension in Premature Infants with Bronchopulmonary Dysplasia. Toxics, 9(4), . https://doi.org/10.3390/toxics9040075
Jenkins, Randall, et al. "Elimination of Intravenous Di-2-Ethylhexyl Phthalate Exposure Abrogates Most Neonatal Hypertension in Premature Infants with Bronchopulmonary Dysplasia." Toxics vol. 9,4 (2021). doi: https://doi.org/10.3390/toxics9040075
Jenkins R, Farnbach K, Iragorri S. Elimination of Intravenous Di-2-Ethylhexyl Phthalate Exposure Abrogates Most Neonatal Hypertension in Premature Infants with Bronchopulmonary Dysplasia. Toxics. 2021 Apr 02;9(4). doi: 10.3390/toxics9040075. PMID: 33918157; PMCID: PMC8067010.
Copy
Download .nbib